Return to Vaccination News Home Page
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
![]() |
| HOME | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | HELP |
Human Infection Due to
Recombinant Vaccinia–Rabies Glycoprotein Virus
Charles E. Rupprecht, V.M.D., Ph.D., Leonard Blass, M.D., Kathy Smith, D.V.M., Lillian A. Orciari, M.S., Michael Niezgoda, M.S., Sylvia G. Whitfield, M.S., Robert V. Gibbons, M.D., Marta Guerra, D.V.M., Ph.D., and Cathleen A. Hanlon, V.M.D., Ph.D.
|
|||
Rabies is a fatal viral disease transmitted from animals to
humans. It causes more than 35,000 human deaths per year.1 Successful
application of veterinary vaccines can eliminate canine rabies
in an area, but control of rabies in free-ranging carnivores requires
other strategies, such as oral vaccination.2 Live viral
vaccines containing modified live rabies or recombinant vaccinia–rabies
glycoprotein virus, placed in a bait, are used for disease control
in Europe and North America.2,3,4,5 In the United States, more
than 22 million doses of vaccinia–rabies glycoprotein vaccine
were distributed from 1990 to 2000,
Case Report
Methods
Results
Discussion
References
|
|||
HOME | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | HELP Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2003 Massachusetts Medical Society. All rights reserved. |
Return to Vaccination News Home Page
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.